Rising drug prices drive US manufacturers’ revenues, analysis findsBMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h5376 (Published 07 October 2015) Cite this as: BMJ 2015;351:h5376
- Michael McCarthy
Drug price rises are contributing three times more to US drug company revenues than are increases in the volume of their prescription sales, shows an analysis of corporate filings and industry data conducted by the Wall Street Journal.
The analysis,1 reported on 5 October by the newspaper’s biotechnology reporter, Joseph Walker, found that wholesale price increases among the 30 top selling drugs sold by pharmacies in the United States averaged …
Log in using your username and password
Log in through your institution
Sign up for a free trial